Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability

[1]  L. Huang,et al.  Carrot and stick: HIF-α engages c-Myc in hypoxic adaptation , 2008, Cell Death and Differentiation.

[2]  G. Mundy.  The premetastatic niche , 2008 .

[3]  Marianne Koritzinsky,et al.  Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. , 2008, Cancer research.

[4]  Y. Pommier,et al.  Homologous recombination is the principal pathway for the repair of DNA damage induced by tirapazamine in mammalian cells. , 2008, Cancer research.

[5]  G. Semenza.  Evaluation of HIF-1 inhibitors as anticancer agents. , 2007, Drug discovery today.

[6]  Jonathan Pevsner,et al.  HIF-dependent antitumorigenic effect of antioxidants in vivo. , 2007, Cancer cell.

[7]  Jens Overgaard,et al.  Hypoxic radiosensitization: adored and ignored. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Hill,et al.  Hypoxia enhances metastatic efficiency in HT1080 fibrosarcoma cells by increasing cell survival in lungs, not cell adhesion and invasion. , 2007, Cancer research.

[9]  C. Lehner,et al.  Rapid effects of acute anoxia on spindle kinetochore interactions activate the mitotic spindle checkpoint , 2007, Journal of Cell Science.

[10]  N. Chandel,et al.  Mitochondrial oxygen sensing: regulation of hypoxia-inducible factor by mitochondrial generated reactive oxygen species. , 2007, Essays in biochemistry.

[11]  P. Wardman,et al.  Chemical radiosensitizers for use in radiotherapy. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[12]  L. Huang,et al.  Hypoxic Suppression of the Cell Cycle Gene CDC25A in Tumor Cells , 2007, Cell cycle.

[13]  P. Glazer,et al.  Co-repression of mismatch repair gene expression by hypoxia in cancer cells: role of the Myc/Max network. , 2007, Cancer letters.

[14]  T. Helleday,et al.  DNA double-strand break repair: from mechanistic understanding to cancer treatment. , 2007, DNA repair.

[15]  R. Bristow,et al.  Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies. , 2007, Future oncology.

[16]  P. Lambin,et al.  Phosphorylation of eIF2alpha is required for mRNA translation inhibition and survival during moderate hypoxia. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  M. Barton,et al.  Hypoxia-induced and stress-specific changes in chromatin structure and function. , 2007, Mutation research.

[18]  Akiko Shimamura,et al.  Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. , 2007, The Journal of clinical investigation.

[19]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[20]  Mark W. Dewhirst,et al.  Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment , 2007, Cancer and Metastasis Reviews.

[21]  John D Gordan,et al.  HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. , 2007, Cancer cell.

[22]  P. Glazer,et al.  Regulation of DNA repair in hypoxic cancer cells , 2007, Cancer and Metastasis Reviews.

[23]  C. Dang,et al.  Effects of hypoxia on tumor metabolism , 2007, Cancer and Metastasis Reviews.

[24]  R. Hill,et al.  Hypoxia and Metastasis , 2007, Clinical Cancer Research.

[25]  E. Rofstad,et al.  Fluctuating and Diffusion-Limited Hypoxia in Hypoxia-Induced Metastasis , 2007, Clinical Cancer Research.

[26]  P. Glazer,et al.  Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia , 2007, Oncogene.

[27]  I. Petersen.  Antiangiogenesis, anti-VEGF(R) and outlook. , 2007, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[28]  A. Giaccia,et al.  Hypoxia, gene expression, and metastasis , 2007, Cancer and Metastasis Reviews.

[29]  A. Harris,et al.  Hypoxia-induced genetic instability—a calculated mechanism underlying tumor progression , 2007, Journal of Molecular Medicine.

[30]  V. Grégoire,et al.  Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. , 2006, Cancer research.

[31]  S. Rafii,et al.  Preparing the "soil": the premetastatic niche. , 2006, Cancer research.

[32]  R. Silverman,et al.  Genetic susceptibility and oxidative stress in prostate cancer: integrated model with implications for prevention. , 2006, Urology.

[33]  L. Huang,et al.  The phosphorylation status of PAS‐B distinguishes HIF‐1α from HIF‐2α in NBS1 repression , 2006 .

[34]  D. Ron,et al.  Perk-Dependent Translational Regulation Promotes Tumor Cell Adaptation and Angiogenesis in Response to Hypoxic Stress , 2006, Molecular and Cellular Biology.

[35]  P. Schumacker,et al.  Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia , 2006, Experimental physiology.

[36]  Alan Ashworth,et al.  Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. , 2006, Cancer research.

[37]  I. Tannock,et al.  Drug penetration in solid tumours , 2006, Nature Reviews Cancer.

[38]  R. Kuhn,et al.  RORA, a large common fragile site gene, is involved in cellular stress response , 2006, Oncogene.

[39]  Quynh-Thu Le,et al.  Lysyl oxidase is essential for hypoxia-induced metastasis , 2006, Nature.

[40]  P. Lambin,et al.  Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control , 2006, The EMBO journal.

[41]  S. Welford,et al.  DNA Damage during Reoxygenation Elicits a Chk2-Dependent Checkpoint Response , 2006, Molecular and Cellular Biology.

[42]  Russell G. Jones,et al.  Hypoxia-induced energy stress regulates mRNA translation and cell growth. , 2006, Molecular cell.

[43]  A. Begg,et al.  Resistance of hypoxic cells to ionizing radiation is influenced by homologous recombination status. , 2006, International journal of radiation oncology, biology, physics.

[44]  Trevor Hastie,et al.  Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers , 2006, PLoS medicine.

[45]  M Ashcroft,et al.  Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms , 2006, Oncogene.

[46]  James L Tatum,et al.  Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy , 2006, International journal of radiation biology.

[47]  R. Bristow,et al.  Radiation and new molecular agents part I: targeting ATM-ATR checkpoints, DNA repair, and the proteasome. , 2006, Seminars in radiation oncology.

[48]  B. Larrivée,et al.  Growth of V79 Cells as Xenograft Tumors Promotes Multicellular Resistance but does not Increase Spontaneous or Radiation-Induced Mutant Frequency , 2005, Radiation research.

[49]  S. Gibson,et al.  Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner. , 2005, Cancer research.

[50]  E. Papp-Szabó,et al.  Microenvironmental influences on mutagenesis in mammary epithelial cells , 2005, International journal of cancer.

[51]  B. Wouters,et al.  Control of the hypoxic response through regulation of mRNA translation. , 2005, Seminars in cell & developmental biology.

[52]  R. Bristow,et al.  Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[53]  P. Lambin,et al.  The hypoxic proteome is influenced by gene-specific changes in mRNA translation. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[54]  M. Dewhirst,et al.  Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. , 2005, Cancer cell.

[55]  F. Kaper,et al.  Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. , 2005, Cancer research.

[56]  Thomas Helleday,et al.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase , 2005, Nature.

[57]  Alan Ashworth,et al.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.

[58]  A. Harris,et al.  HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression , 2005 .

[59]  P. Jeggo,et al.  The life and death of DNA-PK , 2005, Oncogene.

[60]  P. Glazer,et al.  Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. , 2005, Mutation research.

[61]  D. V. van Gent,et al.  The mechanism of non-homologous end-joining: a synopsis of synapsis. , 2004, DNA repair.

[62]  Jeremy M. Stark,et al.  Genetic Steps of Mammalian Homologous Repair with Distinct Mutagenic Consequences , 2004, Molecular and Cellular Biology.

[63]  Paul Lizardi,et al.  Down-Regulation of Rad51 and Decreased Homologous Recombination in Hypoxic Cancer Cells , 2004, Molecular and Cellular Biology.

[64]  A. Giaccia,et al.  Hypoxic gene expression and metastasis , 2004, Cancer and Metastasis Reviews.

[65]  D. W. Kim,et al.  Association of DNA-dependent protein kinase with hypoxia inducible factor-1 and its implication in resistance to anticancer drugs in hypoxic tumor cells , 2004, Experimental & Molecular Medicine.

[66]  R. Hill,et al.  Hypoxia Enhances Metastatic Efficiency by Up-Regulating Mdm2 in KHT Cells and Increasing Resistance to Apoptosis , 2004, Cancer Research.

[67]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[68]  Soldatenkov Va,et al.  DNA-Binding Properties of Poly(ADP-Ribose) Polymerase: A Target for Anti-Cancer Therapy , 2004 .

[69]  S. Kyo,et al.  HIF-1-mediated activation of telomerase in cervical cancer cells , 2004, Oncogene.

[70]  Richard P. Hill,et al.  Acute Hypoxia Enhances Spontaneous Lymph Node Metastasis in an Orthotopic Murine Model of Human Cervical Carcinoma , 2004, Cancer Research.

[71]  P. Olive,et al.  Phosphorylation of histone H2AX as a measure of radiosensitivity. , 2004, International journal of radiation oncology, biology, physics.

[72]  V. Potaman,et al.  DNA-binding properties of poly(ADP-ribose) polymerase: a target for anticancer therapy. , 2004, Current drug targets.

[73]  S. Lambert,et al.  Overexpression of mammalian Rad51 does not stimulate tumorigenesis while a dominant-negative Rad51 affects centrosome fragmentation, ploidy and stimulates tumorigenesis, in p53-defective CHO cells , 2003, Oncogene.

[74]  A. Giaccia,et al.  HIF-1 as a target for drug development , 2003, Nature Reviews Drug Discovery.

[75]  S. Powell,et al.  Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation , 2003, Oncogene.

[76]  Aoife M Shannon,et al.  Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. , 2003, Cancer treatment reviews.

[77]  R. Wenger,et al.  The hypoxia-inducible factor-1α is a negative factor for tumor therapy , 2003, Oncogene.

[78]  P. Glazer,et al.  Decreased Expression of the DNA Mismatch Repair Gene Mlh1 under Hypoxic Stress in Mammalian Cells , 2003, Molecular and Cellular Biology.

[79]  A. Giaccia,et al.  ATR/ATM Targets Are Phosphorylated by ATR in Response to Hypoxia and ATM in Response to Reoxygenation* , 2003, The Journal of Biological Chemistry.

[80]  Friedo Zölzer,et al.  Increased radiosensitivity with chronic hypoxia in four human tumor cell lines. , 2002, International journal of radiation oncology, biology, physics.

[81]  A. Koong,et al.  Estimating DNA repair by sequential evaluation of head and neck tumor radiation sensitivity using the comet assay. , 2002, Archives of otolaryngology--head & neck surgery.

[82]  D. Murray,et al.  Sensitivity of nucleotide excision repair-deficient human cells to ionizing radiation and cyclophosphamide. , 2002, Anticancer research.

[83]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[84]  S. Freier,et al.  Elevated levels of Rad51 recombination protein in tumor cells. , 2002, Cancer research.

[85]  R. Hill,et al.  Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. , 2001, Cancer research.

[86]  O. S. Nielsen,et al.  Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations , 2001, British Journal of Cancer.

[87]  J. Hoeijmakers,et al.  Chromosomal stability and the DNA double-stranded break connection , 2001, Nature Reviews Genetics.

[88]  B. Wouters,et al.  Cell cycle progression and radiation survival following prolonged hypoxia and re-oxygenation , 2001, International journal of radiation biology.

[89]  M. Dewhirst,et al.  Persistent genetic instability in cancer cells induced by non-DNA-damaging stress exposures. , 2001, Cancer research.

[90]  H. Birnboim,et al.  Effect of dietary vitamin E on spontaneous or nitric oxide donor-induced mutations in a mouse tumor model. , 2000, Journal of the National Cancer Institute.

[91]  E. Rofstad.  Microenvironment-induced cancer metastasis , 2000, International journal of radiation biology.

[92]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[93]  F. Toledo,et al.  A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. , 1998, Molecular cell.

[94]  L. Huang,et al.  Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway , 1998 .

[95]  David J. Chen,et al.  Ku70 Is Required for DNA Repair but Not for T Cell Antigen Receptor Gene Recombination In Vivo , 1997, The Journal of experimental medicine.

[96]  J. Caro,et al.  Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. , 1997, The Journal of biological chemistry.

[97]  F. Toledo,et al.  Expression of Fragile Sites Triggers Intrachromosomal Mammalian Gene Amplification and Sets Boundaries to Early Amplicons , 1997, Cell.

[98]  P. Glazer,et al.  Genetic instability induced by the tumor microenvironment. , 1996, Cancer research.

[99]  P Vaupel,et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.

[100]  D. Murray,et al.  ERCC1/ERCC4 5'-endonuclease activity as a determinant of hypoxic cell radiosensitivity. , 1996, International journal of radiation biology.

[101]  M. Dewhirst,et al.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.

[102]  David E. Housman,et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.

[103]  C. Koch,et al.  Radiation-induced DNA damage in tumors and normal tissues. III. Oxygen dependence of the formation of strand breaks and DNA-protein crosslinks. , 1995, Radiation research.

[104]  T. Graeber,et al.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.

[105]  J. Brown,et al.  Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation. , 1992, Cancer research.

[106]  M. Kovacs,et al.  The prediction of human tumor radiosensitivity in situ: an approach using chromosome aberrations detected by fluorescence in situ hybridization. , 1992, International journal of radiation oncology, biology, physics.

[107]  M. Frankenberg-Schwager,et al.  Different oxygen enhancement ratios for induced and unrejoined DNA double-strand breaks in eukaryotic cells. , 1991, Radiation research.

[108]  I. Tannock,et al.  Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines. , 1990, Journal of the National Cancer Institute.

[109]  R. Hill,et al.  Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. , 1990, Journal of the National Cancer Institute.

[110]  Richard P. Hill,et al.  The Basic Science of Oncology , 1989 .

[111]  R. Hill,et al.  Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[112]  D. Shrieve,et al.  The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-radiation and hypoxic cell radiosensitizers. , 1985, International journal of radiation biology and related studies in physics, chemistry, and medicine.